Comparison of immunotherapy with chemotherapy on triple-negative breast cancer

Ruiting Zhou

doi:10.1117/12.2692921

7 September 2023 Comparison of immunotherapy with chemotherapy on triple-negative breast cancer

Ruiting Zhou

Proceedings Volume 12789, International Conference on Modern Medicine and Global Health (ICMMGH 2023); 127891H (2023) https://doi.org/10.1117/12.2692921
Event: International Conference on Modern Medicine and Global Health (ICMMGH 2023), 2023, Oxford, United Kingdom

Abstract

Breast cancer that is triple-negative (TNBC) has a poor prognosis and is highly prone to relapse and metastasis. The specificity of TNBC makes it difficult to determine the standard and best treatment for patients because TNBC does not have three hormone receptors like other types of breast cancer (ER+, PR+ HER2+). Currently, a standard treatment for triple-negative breast cancer is chemotherapy. As well as being effective as a treatment method, novel immunotherapy has also risen in popularity. It is true that there are numerous articles introducing chemotherapy and immunotherapy in detail, but few of these papers compare the two. The purpose of this article is to summarize three common types of chemotherapy and two types of immunotherapies. Furthermore, a comparison based on resistance, toxicity, survival, and response rates shows that immunotherapy has a few advantages over chemotherapy, but it still has some disadvantages. However, a combination of both immunotherapy and chemotherapy is more effective for TNBC patients.

Citation Download Citation

Ruiting Zhou "Comparison of immunotherapy with chemotherapy on triple-negative breast cancer", Proc. SPIE 12789, International Conference on Modern Medicine and Global Health (ICMMGH 2023), 127891H (7 September 2023); https://doi.org/10.1117/12.2692921

ACCESS THE FULL ARTICLE

INSTITUTIONAL
Select your institution to access the SPIE Digital Library.

SELECT YOUR INSTITUTION

PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.

PERSONAL SIGN IN

No SPIE Account? Create one

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available